World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
15160
World Ranking
3684
National Ranking
1697

Nicole Frahm publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nicole Frahm sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 142 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nicole Frahm D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nicole Frahm sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Nicole Frahm is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research spans areas primarily within immunology, microbiology, and medicine, with a strong focus on infectious diseases and virology. The subfields that characterize their work include immunology, infectious diseases, virology, epidemiology, and molecular biology.

The scientist's research covers key topics such as HIV research and treatment, tuberculosis research and epidemiology, mycobacterium research and diagnosis, immune cell function and interaction, T-cell and B-cell immunology, vaccines and immunoinformatics approaches, as well as immunotherapy and immune responses.

Nicole Frahm has published multiple papers in notable scientific journals. Recent publications include:

  • "Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies" (2022, Clinical Microbiology Reviews)
  • "Update on the Diagnosis of Tuberculosis" (2023, Clinical Microbiology and Infection)
  • "Safety and Immune Responses after a 12-month Booster in Healthy HIV-Uninfected Adults in HVTN 100 in South Africa: A Randomized Double-Blind Placebo-Controlled Trial of ALVAC-HIV (vCP2438) and Bivalent Subtype C gp120/MF59 Vaccines" (2020, PLoS Medicine)
  • "Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein" (2020, Clinical Infectious Diseases)
  • "The Quest for Vaccine-Induced Immune Correlates of Protection against Tuberculosis" (2022, Vaccine Insights)

Frequently, Nicole Frahm collaborates with colleagues in the field. Some of the most common coauthors are:

  • M. Juliana McElrath
  • Georgia D. Tomaras
  • Zoe Moodie
  • Kristen W. Cohen
  • Peter B. Gilbert

The scientist's work is regularly published in venues including:

  • PLoS Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Microbiology Reviews
  • Clinical Microbiology and Infection
  • New England Journal of Medicine

Best Publications

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • The epigenetic landscape of T cell exhaustion

    Debattama R. Sen;James Kaminski;R. Anthony Barnitz;Makoto Kurachi

  • HLA class I supertypes: a revised and updated classification

    John Sidney;Bjoern Peters;Nicole Frahm;Christian Brander

  • Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Scott M. Hammer;Magdalena E. Sobieszczyk;Holly Janes;Shelly T. Karuna

  • Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized Clinical Trial

    Iain D. Milligan;Malick M. Gibani;Richard Sewell;Elizabeth A. Clutterbuck

  • Relative Dominance of Gag p24-Specific Cytotoxic T Lymphocytes Is Associated with Human Immunodeficiency Virus Control

    Rosario Zuñiga;Aldo Lucchetti;Patricia Galvan;Shyla Sanchez

  • Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.

    Amy W. Chung;Amy W. Chung;Manu P. Kumar;Kelly B. Arnold;Wen Han Yu;Wen Han Yu

  • Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities

    Nicole Frahm;B. T. Korber;B. T. Korber;C. M. Adams;J. J. Szinger

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  • Founder effects in the assessment of HIV polymorphisms and HLA allele associations.

    Tanmoy Bhattacharya;Tanmoy Bhattacharya;Marcus Daniels;David Heckerman;Brian Foley

  • MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands

    Angela Meier;Galit Alter;Nicole Frahm;Harlyn Sidhu

  • Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice

    Diana M. Brainard;Edward Seung;Nicole Frahm;Nicole Frahm;Annaiah Cariappa

  • COMPASS identifies T-cell subsets correlated with clinical outcomes

    Lin Lin;Greg Finak;Kevin Ushey;Chetan Seshadri

  • HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphocyte Recognition.

    Toshiyuki Miura;Mark A. Brockman;Arne Schneidewind;Michael Lobritz

  • Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes.

    Nicole Frahm;Photini Kiepiela;Sharon Adams;Caitlyn H Linde

  • Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial

    Morgane Rolland;Sodsai Tovanabutra;Allan C deCamp;Nicole Frahm

  • Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1

    Nicola Borthwick;Tina Ahmed;Beatrice Ondondo;Peter Hayes

  • A Quantitative Analysis of the Variables Affecting the Repertoire of T Cell Specificities Recognized after Vaccinia Virus Infection

    Erika Assarsson;John Sidney;Carla Oseroff;Valerie Pasquetto

  • Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1

    Zabrina L Brumme;Zabrina L Brumme;Zabrina L Brumme;Chanson J Brumme;Chanson J Brumme;David Heckerman;Bette T Korber;Bette T Korber

  • Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides

    Daniel E. Kaufmann;Paul M. Bailey;John Sidney;Bradford Wagner

Frequent Co-Authors

Bruce D. Walker
Bruce D. Walker Harvard University
M. Juliana McElrath
M. Juliana McElrath University of Washington
Christian Brander
Christian Brander University of Vic - Central University of Catalonia
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Bette T. Korber
Bette T. Korber Los Alamos National Laboratory
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
David Heckerman
David Heckerman Microsoft (United States)
Todd M. Allen
Todd M. Allen Harvard University
James I. Mullins
James I. Mullins University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring advanced nursing degrees can open diverse career paths in healthcare and research. Many students consider programs like the what is the easiest np program to balance quality education with manageable coursework. These options often provide flexible learning schedules suitable for working professionals.

Specializing further, psychiatric nursing is a vital field connected to Immunology and overall health. Some of the top pmhnp programs offer strong clinical placements, providing students with hands-on experience that is crucial for career success. Accessibility and affordability are also key factors, as highlighted by the availability of the cheapest online pmhnp programs.

Graduates who pursue a Doctor of Nursing Practice (DNP) often see promising earnings, with variations depending on location and specialization. Understanding the dnp salary by state can help prospective students make informed decisions about their education and career trajectory.

Best Scientists Citing Nicole Frahm

Trending Scientists

Recently Published Articles